British Patient Capital

British Patient Capital British Patient Capital is the UK government's answer to a persistent market failure: the lack of long-term, patient capital for science and technology scale-ups. Launched in 2018 as a commercial subsidiary of the British Business Bank with an initial £2.5B mandate, it has grown to £3.125B total AUM with £2.3B committed, making it the UK's largest domestic investor in venture and venture growth capital. The Chancellor extended the mandate from 2028 to 2033, signaling sust